CFLT Stock Cash Flow Statements

Confluent Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Confluent Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30

cash flows from operating activities
net income	-81,950,000	-67,574,000	-88,054,000	-74,144,000	-89,900,000	-92,967,000	-94,096,000	-92,670,000	-103,425,000	-152,555,000	-105,884,000	-116,049,000	-117,631,000	-112,987,000	-114,439,000	-95,666,000
adjustments to reconcile net income to cash from operating activities:
depreciation and amortization	7,344,000	6,605,000	6,234,000	5,702,000	5,842,000	4,311,000	3,923,000	3,609,000	3,256,000	3,122,000	2,485,000	2,075,000	1,810,000	1,250,000	1,192,000	897,000
net accretion of discounts on marketable securities	-5,952,000	-6,847,000	-8,205,000	-9,294,000	-9,871,000	-10,396,000
amortization of debt issuance costs	957,000	945,000	966,000	964,000	953,000	953,000	963,000	961,000	950,000	939,000	958,000	958,000	947,000	936,000
amortization of deferred contract acquisition costs	14,323,000	13,931,000	14,213,000	13,949,000	13,334,000	12,762,000	12,428,000	11,923,000	11,053,000	10,484,000	10,286,000	9,658,000	8,925,000	8,470,000	8,375,000	6,739,000
non-cash operating lease costs	1,089,000	1,075,000	1,172,000	940,000	969,000	885,000	874,000	934,000	977,000	1,207,000	1,991,000	2,142,000	2,200,000	2,275,000	2,424,000	2,962,000
stock-based compensation, net of amounts capitalized	101,997,000	92,575,000	102,924,000	98,307,000	99,107,000	95,322,000	88,871,000	89,514,000	92,159,000	79,289,000	76,028,000	75,393,000	68,866,000	57,369,000	58,072,000	49,683,000
deferred income taxes	177,000	-17,338,000	46,000	-111,000	-273,000	615,000	1,864,000	15,000	5,000	5,000	-283,000	20,000	30,000	-4,000	-394,000	-1,000
other	1,107,000	454,000	1,675,000	485,000	361,000	849,000	-756,000	2,263,000	572,000	279,000	504,000	321,000	355,000	204,000	157,000	1,023,000
changes in operating assets and liabilities, net of effects of business combinations:
accounts receivable	-60,321,000	15,414,000	-36,327,000	-21,577,000	-58,018,000	29,360,000	-47,453,000	5,153,000	-19,361,000	8,068,000	-35,665,000	6,047,000	-25,244,000	12,782,000	-21,642,000	979,000
deferred contract acquisition costs	-15,236,000	-10,410,000	-15,974,000	-12,244,000	-15,296,000	-9,732,000	-21,781,000	-15,607,000	-13,806,000	-10,160,000	-20,724,000	-19,354,000	-10,643,000	-12,080,000	-20,332,000	-11,244,000
prepaid expenses and other assets	-19,988,000	1,515,000	1,205,000	-2,135,000	3,703,000	-1,929,000	3,438,000	-7,768,000	-9,198,000	3,141,000	3,248,000	-977,000	-12,136,000	-7,985,000	-14,027,000	-2,616,000
accounts payable	5,356,000	-1,274,000	-8,159,000	1,231,000	11,987,000	-4,932,000	4,756,000	-488,000	-7,395,000	-11,325,000	7,132,000	-1,004,000	7,275,000	177,000	4,406,000	1,366,000
accrued expenses and other liabilities	21,149,000	-49,828,000	32,861,000	-10,363,000	46,893,000	-43,752,000	43,368,000	10,413,000	24,109,000	-16,557,000	8,227,000	-35,000	24,609,000	-22,853,000	29,642,000	18,597,000
operating lease liabilities	-2,205,000	-2,177,000	-4,191,000	-2,020,000	-1,994,000	-1,935,000	-1,917,000	-1,808,000	-1,756,000	-1,998,000	-2,270,000	-2,029,000	-2,413,000	-2,497,000	-2,650,000	-2,834,000
deferred revenue	50,268,000	-3,820,000	34,825,000	25,923,000	793,000	-5,368,000	29,237,000	-4,204,000	3,388,000	1,755,000	32,911,000	4,187,000	20,047,000	19,207,000	44,383,000	11,550,000
net cash from operating activities	18,115,000	-26,754,000	35,211,000	15,613,000	8,590,000	-25,954,000	12,235,000	-9,060,000	-29,060,000	-77,772,000	-27,078,000	-41,752,000	-33,472,000	-55,031,000	-23,876,000	-18,029,000
capex	-7,110,000	-6,235,000	-6,089,000	-6,276,000	-5,881,000	-5,725,000	-5,415,000	-4,023,000	-6,139,000	-5,102,000	-3,787,000	-3,832,000	-3,440,000	-3,396,000	-2,843,000	-2,615,000
free cash flows	11,005,000	-32,989,000	29,122,000	9,337,000	2,709,000	-31,679,000	6,820,000	-13,083,000	-35,199,000	-82,874,000	-30,865,000	-45,584,000	-36,912,000	-58,427,000	-26,719,000	-20,644,000
cash flows from investing activities
capitalization of internal-use software costs	-6,191,000	-4,806,000	-5,420,000	-5,669,000	-4,776,000	-5,539,000	-4,299,000	-3,660,000	-5,330,000	-4,556,000	-2,781,000	-2,788,000	-2,256,000	-2,509,000	-1,479,000	-2,052,000
purchases of marketable securities	-465,993,000	-405,235,000	-367,357,000	-273,169,000	-455,883,000	-443,307,000	-351,105,000	-235,824,000	-546,408,000	-453,356,000	-528,660,000	-355,886,000	-763,479,000	-403,883,000	-284,683,000	-322,941,000
sales of marketable securities			2,567,000	0
maturities of marketable securities	458,470,000	299,467,000	381,127,000	374,281,000	403,489,000	432,267,000	374,612,000	228,328,000	523,606,000	451,777,000	482,899,000	347,000,000	275,114,000	95,545,000	91,275,000	57,693,000
purchases of investments in privately-held companies			0	-1,250,000
purchases of property and equipment	-919,000	-1,429,000	-669,000	-607,000	-1,105,000	-186,000	-1,116,000	-363,000	-809,000	-546,000	-1,006,000	-1,044,000	-1,184,000	-887,000	-1,364,000	-563,000
net cash from investing activities	-8,489,000	-112,003,000	10,248,000	-21,930,000	-46,531,000	-16,765,000	8,092,000	-11,519,000	-28,941,000	-52,483,000	-49,548,000	-12,718,000	-491,805,000	-311,734,000	-196,251,000	-267,860,000
cash flows from financing activities
proceeds from issuance of common stock upon exercise of vested options	6,062,000	16,606,000	19,504,000	8,835,000	13,096,000	14,401,000	10,974,000	14,673,000	27,492,000	20,780,000	8,329,000	9,749,000	7,947,000	16,436,000	22,611,000	10,421,000
proceeds from issuance of common stock under employee stock purchase plan	0	14,195,000	0	8,367,000	0	15,603,000	0	11,536,000	0	17,172,000	0	18,454,000	0	22,485,000
net cash from financing activities	6,062,000	30,801,000	19,504,000	17,202,000	13,096,000	30,004,000	10,974,000	26,177,000	27,492,000	37,729,000	8,249,000	28,189,000	7,335,000	38,468,000	1,013,346,000	8,240,000
effect of exchange rate changes on cash and cash equivalents	1,342,000	537,000	-1,589,000	393,000	-200,000	-673,000
net decrease in cash and cash equivalents	17,030,000	-107,419,000		11,278,000	-25,045,000	-13,388,000
cash and cash equivalents at beginning of period	0	385,980,000	0	0	0	349,761,000
cash and cash equivalents at end of period	17,030,000	278,561,000	63,374,000	11,278,000	-25,045,000	336,373,000
lease abandonment charges							0	0	0	15,667,000
cash paid for business combinations, net of cash acquired			0
proceeds from issuance of common stock upon early exercise of unvested options											0	0
repurchases of unvested common stock							0
payments of debt issuance costs for convertible senior notes												0	0	-786,000
net increase in cash and cash equivalents
repurchases of unvested options									0	-223,000	-80,000	-14,000
net amortization of (discounts) premiums on marketable securities									-10,588,000	-9,133,000	-6,022,000
common stock charitable donation expense															0	0
proceeds from initial public offering, net of underwriting discounts and commissions															0	0
payments of deferred offering costs															0	-2,205,000
proceeds from convertible senior notes, net of issuance costs
payment for purchase of capped calls
effect of exchange rate changes on cash, cash equivalents, and restricted cash							1,417,000	-1,198,000	-308,000	205,000	2,000	20,000	20,000	-46,000	16,000	-1,000
net increase in cash, cash equivalents, and restricted cash											-68,375,000	-26,261,000	-517,922,000	-328,343,000	793,235,000	-277,650,000
cash, cash equivalents, and restricted cash at beginning of period							0	0	0	435,781,000	0	0	0	1,376,682,000	0	0
cash, cash equivalents, and restricted cash at end of period							32,718,000	4,400,000	-30,817,000	343,460,000	-68,375,000	-26,261,000	-517,922,000	1,048,339,000	793,235,000	-277,650,000
changes in operating assets and liabilities, net of effects of a business combination:
cash paid for a business combination, net of cash acquired								0	0	-45,802,000
net decrease in cash, cash equivalents, and restricted cash								4,400,000	-30,817,000	-92,321,000
changes in operating assets and liabilities:
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
net amortization of premiums or discounts on marketable securities													-469,000	705,000		536,000
proceeds from issuance of common stock upon early exercise of unvested options, net of repurchases														333,000	405,000	24,000
net amortization (accretion) of premiums (discounts) on marketable securities

We provide you with 20 years of cash flow statements for Confluent stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Confluent stock. Explore the full financial landscape of Confluent stock with our expertly curated income statements.

The information provided in this report about Confluent stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.